—

HealthEquity Inc (HQY) — the peer cohort

As of 2026-10-30 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

HealthEquity Inc ranks 5 of 9 in its cohort on the Closelooknet composite (62/100) — the cohort is led by Halozyme Therapeutics Inc at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
HQY HealthEquity Inc 62 75 70 41 ok 4.8%
VEEV Veeva Systems Inc Class A 60 95 75 28 bull 4%
HNGE Hinge Health, Inc. 56 97 63 22 ok 2.7%
BTSG BrightSpring Health Services, Inc. Common Stock 51 81 27 38 ok 9.3%
TEM Tempus AI, Inc. Class A Common Stock 41 87 19 15 bear 30.8%
HALO Halozyme Therapeutics Inc 73 98 94 39 ok 2.3%
ONC BeiGene, Ltd. 65 86 64 31 ok 4.7%
DXCM DexCom Inc 65 73 80 40 watch 11.1%
ARGX argenx NV ADR 63 73 74 29 info 16.8%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-30

Quick answers

Who are HealthEquity Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Veeva Systems Inc Class A (VEEV), Hinge Health, Inc. (HNGE), BrightSpring Health Services, Inc. Common Stock (BTSG), Tempus AI, Inc. Class A Common Stock (TEM), Halozyme Therapeutics Inc (HALO), BeiGene, Ltd. (ONC), DexCom Inc (DXCM), argenx NV ADR (ARGX), as of 2026-10-30.

How does HQY score against its peers?

HealthEquity Inc's composite reads 62/100, ranking 5 of 9 in its cohort as of 2026-10-30; the cohort's highest composite is Halozyme Therapeutics Inc at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.